Lung cancer drug response tied to tumor type: study
Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial.
Read more on Reuters via Yahoo! News
Dendreon Rises After Winning Approval for Cancer Drug (Update2)
April 29 (Bloomberg) — Dendreon Corp. won approval for its first product, a vaccine to fight prostate cancer, after a three-year battle with U.S. regulators. Shares surged the most in a year in New York trading.
Read more on Bloomberg
Research studies concerning resveratrol and prostate cancer have been promising. Researchers believe the results warrant future investigations concerning resveratrol prostate cancer prevention and treatment.
The antioxidant appears to inhibit the growth of cancerous cells, according to studies sponsored by the National Institute of Health in the United States. In later studies concerning resveratrol and prostate cancer, researchers included other phytochemicals, which are plant components with activity similar to, but different from, those of resveratrol.
Some phytochemicals inhibit the grown of cancerous cells while others cause them to commit suicide. Living cells are amazing things. You really wouldn’t believe everything that’s going on within them every minute of every day.
» Read more: Does Resveratrol Prevent Prostate Cancer?